Welcome to CDC Stacks | Use of anthrax vaccine in response to terrorism: supplemental recommendations of the Advisory Committee on Immunization Practices - 7184 | Guidelines and Recommendations
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
Use of anthrax vaccine in response to terrorism: supplemental recommendations of the Advisory Committee on Immunization Practices
Filetype[PDF - 849.94 KB]


Details:
  • Description:
    In December 2000, the Advisory Committee on Immunization Practices (ACIP) released its recommendations for using anthrax vaccine in the United States. Because of recent terrorist attacks involving the intentional exposure of U.S. civilians to Bacillus anthracis spores and concerns that the current anthrax vaccine supply is limited, ACIP developed supplemental recommendations on using anthrax vaccine in response to terrorism. These recommendations supplement the previous ACIP statement in three areas: use of anthrax vaccine for pre-exposure vaccination in the U.S. civilian population, the prevention of anthrax by postexposure prophylaxis (PEP), and recommendations for additional research related to using antimicrobial agents and anthrax vaccine for preventing anthrax

  • Supporting Files:
    No Additional Files
No Related Documents.
You May Also Like: